O'Loughlin Steve

O'Loughlin Steve is listed in filings as Chief Financial Officer at CNS Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including 10 public disclosures. Recent filings connect the profile to CNS Pharmaceuticals, Inc. (CNSP) and Actinium Pharmaceuticals, Inc. (ATNM). The current snapshot covers public activity from Apr 2, 2025 to Mar 4, 2026. Reported amounts are shown as $1.3M to $564.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.